News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides
NanoViricides reports progress in Phase IIA Ebola Treatment Clinical Trial for NV-387 Oral Gummies, evaluating dosage regimens and efficacy against Ebola Bundibugyo virus, with safety and tolerability focus -